Atrás
Precio Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
Gráfico del Precio de Acciones 2315.HK
BIOCYTOGEN-B (2315.HK)
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
HK$43.28
-0.55%
$-0.24
Mercado cerrado: Jan 16, 16:00:00 HKT
Estadísticas clave
Cierre Anterior
$43
Precio de apertura
$43.52
Rango del día
$41 - $43.88
Rango de 52 semanas
$7.25 - $48.26
Volumen
657.0K
Volumen promedio
1.0M
EPS (TTM)
0.37
Rendimiento de dividendos
--
Cap. de mercado
$4.6B
¿Qué es BIOCYTOGEN-B?
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing and currently employs 1,306 full-time employees. The company went IPO on 2022-09-01. The firm utilizes its self-developed RenMice fully human antibody and T-cell receptor (TCR) mouse platform for large-scale drug discovery and development targeting potential drug targets in the human body. The Company’s main businesses include the sale of innovative animal models, pre-clinical pharmacology and efficacy evaluation services, and antibody development. The firm is also engaged in the provision of gene-editing services. The firm operates its businesses in the domestic market and overseas markets.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
